4.6 Editorial Material

A new mechanism for protection of dopaminergic neurons mediated by astrocytes

期刊

NEURAL REGENERATION RESEARCH
卷 10, 期 8, 页码 1225-1227

出版社

WOLTERS KLUWER MEDKNOW PUBLICATIONS
DOI: 10.4103/1673-5374.162750

关键词

-

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Neurosciences

KM-34, a Novel Antioxidant Compound, Protects against 6-Hydroxydopamine-Induced Mitochondrial Damage and Neurotoxicity

Luis Arturo Fonseca-Fonseca, Yanier Nunez-Figueredo, Jeney Ramirez Sanchez, Maylin Wong Guerra, Estael Ochoa-Rodriguez, Yamila Verdecia-Reyes, Rene Delgado Hernadez, Noelio J. Menezes-Filho, Teresa Cristina Silva Costa, Wagno Alcantara de Santana, Joana L. Oliveira, Juan Segura-Aguilar, Victor Diogenes Amaral da Silva, Silva Lima Costa

NEUROTOXICITY RESEARCH (2019)

Review Neurosciences

Neurotoxins as Preclinical Models for Parkinson's Disease

Juan Segura-Aguilar

NEUROTOXICITY RESEARCH (2018)

Article Neurosciences

Aminochrome decreases NGF, GDNF and induces neuroinflammation in organotypic midbrain slice cultures

Fillipe M. de Araujo, Rafael S. Ferreir, Cleide S. Souza, Cleonice Creusa dos Santos, Tacio L. R. S. Rodrigues, Juliana Helena C. e Silva, Juciano Gasparotto, Daniel Pens Gelain, Ramon S. El-Bacha, Maria de Fatima D. Costa, Jose Claudio M. Fonseca, Juan Segura-Aguilar, Silvia L. Costa, Victor Diogenes A. Silva

NEUROTOXICOLOGY (2018)

Article Neurosciences

DT-Diaphorase Prevents Aminochrome-Induced Lysosome Dysfunction in SH-SY5Y Cells

Catalina Melendez, Patricia Munoz, Juan Segura-Aguilar

NEUROTOXICITY RESEARCH (2019)

Article Biochemistry & Molecular Biology

The importance of choosing a preclinical model that reflects what happens in Parkinson's disease

Juan Segura-Aguilar

NEUROCHEMISTRY INTERNATIONAL (2019)

Article Neurosciences

The Flavonoid Agathisflavone from Poincianella pyramidalis Prevents Aminochrome Neurotoxicity

Cleonice Creusa Santos, Patricia Munoz, Aurea Maria A. N. Almeida, Juceni Pereira de Lima David, Jorge Mauricio David, Silvia Lima Costa, Juan Segura-Aguilar, Victor Diogenes Amaral Silva

NEUROTOXICITY RESEARCH (2020)

Article Neurosciences

Cellular Trafficking of Glutathione Transferase M2-2 Between U373MG and SHSY-S7 Cells is Mediated by Exosomes

Raul Valdes, Alicia Armijo, Patricia Munoz, Kjell Hultenby, Andres Hagg, Jose Inzunza, Ivan Nalvarte, Mukesh Varshney, Bengt Mannervik, Juan Segura-Aguilar

Summary: The enzyme glutathione transferase M2-2 is shown to prevent the toxic effects of aminochrome by catalyzing its conjugation. It is released in exosomes from U373MG cells, providing a mechanism for intercellular transport of the enzyme. This mechanism may help astrocytes protect dopaminergic neurons against aminochrome-induced damage.

NEUROTOXICITY RESEARCH (2021)

Article Cell & Tissue Engineering

Generation of nonviral integration-free human iPS cell line KISCOi001-A from normal human fibroblasts, under defined xeno-free and feeder-free conditions

Jose Inzunza, Jonathan Arias-Fuenzalida, Juan Segura-Aguilar, Ivan Nalvarte, Mukesh Varshney

Summary: KISCOi001-A is a healthy, transgene-free human induced pluripotent stem cell line cultured under xeno-free conditions. The cell line expresses stem cell markers and can differentiate into cells of ectoderm, endoderm, and mesoderm, while genomic assays confirm its identity and karyotype stability.

STEM CELL RESEARCH (2021)

Review Cell Biology

Astrocytes protect dopaminergic neurons against aminochrome neurotoxicity

Juan Segura-Aguilar, Bengt Mannervik, Jose Inzunza, Mukesh Varshney, Ivan Nalvarte, Patricia Munoz

Summary: Astrocytes play a vital role in protecting neurons by providing energy, defending against excitotoxicity, metabolizing fatty acids, and converting glutamate. A recent discovery suggests that astrocytes also protect dopamine neurons from neurotoxicity through the secretion of certain enzymes.

NEURAL REGENERATION RESEARCH (2022)

Review Biochemistry & Molecular Biology

Neuroprotection against Aminochrome Neurotoxicity: Glutathione Transferase M2-2 and DT-Diaphorase

Juan Segura-Aguilar, Patricia Munoz, Jose Inzunza, Mukesh Varshney, Ivan Nalvarte, Bengt Mannervik

Summary: Glutathione is an important antioxidant that plays a crucial role in cellular protection and detoxification. Aminochrome may trigger neurodegenerative processes in the nigrostriatal neurons, but the exact triggers are still unknown. There are protective mechanisms against aminochrome neurotoxicity in the brain.

ANTIOXIDANTS (2022)

Review Biochemistry & Molecular Biology

A Preclinical Model for Parkinson's Disease Based on Transcriptional Gene Activation via KEAP1/NRF2 to Develop New Antioxidant Therapies

Juan Segura-Aguilar, Bengt Mannervik

Summary: Investigations on antioxidants for Parkinson's disease have been unsuccessful due to the use of preclinical models that do not accurately represent its neurodegenerative process. Aminochrome, an endogenous neurotoxin formed in the neurons where degeneration occurs, seems to be a promising alternative target. Neuromelanin synthesis, despite involving potentially toxic ortho-quinones, is considered harmless due to the protective roles of enzymes and astrocytes. Increasing the expression of these protective factors may prevent the degeneration of dopaminergic neurons. Exploring phytochemical activators of these protective factors could be an interesting avenue of research.

ANTIOXIDANTS (2023)

Letter Biochemistry & Molecular Biology

Why are neuromelanin-containing dopaminergic neurons lost in idiopathic Parkinson's disease?

Sandro Huenchuguala, Juan Segura-Aguilar

CELLULAR AND MOLECULAR LIFE SCIENCES (2023)

Review Biochemistry & Molecular Biology

On the Role of Iron in Idiopathic Parkinson's Disease

Sandro Huenchuguala, Juan Segura-Aguilar

Summary: Iron plays a fundamental role in various aspects of human life, but an imbalance in iron levels can lead to certain pathologies. Maintaining iron homeostasis is crucial in preventing these pathologies. While there is evidence suggesting iron's involvement in the degenerative process of Parkinson's disease, clinical studies have not shown positive effects of iron chelators in treating the disease.

BIOMEDICINES (2023)

暂无数据